SlideShare a Scribd company logo
1 of 10
Download to read offline
How e-Patients are
Learning and Sharing
Information about
Pre-Approval Therapies
brian@inspire.com
@teaminspire

Patient-Centered Technologies for Post-Marketing and Real World Data Research
February 6, 2014

Brian Loew, CEO, Inspire

www.Inspire.com

Thursday, February 13, 14
Patients are increasingly seeking and sharing information
online about drugs before FDA approval

Examples from our ovarian, lung, prostate and advanced breast cancer groups:

• “About temsirolimus: Right after my cancer returned 3 months after the completion of the taxol-platinum

regimen, my doctor sent me to the U of Penn to enroll in a study...I was delighted to find that it was reducing the
size of my tumor, though it never completely eliminated it.”

• “If the resistance to Tarceva is due to the T790M mutation, there are two promising drugs in clinical trials right
now. One is from Clovis called CO-1686, the other from AstraZeneca called AZD9291.”

• “Nivolumab 3mg/kg every 2 weeks HAS worked for me one tumor so small no longer measurable. I knew it was
working as I just felt better almost immediately.”

Brian Loew, brian@inspire.com, @teaminspire
Thursday, February 13, 14

www.Inspire.com
More sharing–driven entirely by engaged, insightful patients:

• “The phase 3 trial that is just starting is using Mekinist, which is FDA approved for Melanoma. Your
doc should make a case to your insurance to cover this drug for your treatment and start you on it
outside of the trial.”

• “There is a drug in prostate cancer that targets CLTA-4 in clinical trials.”
• “When deciding between continuing on anti-PD1 trial or switching to chemotherapy, I think you

need to consider at least two things: 1) What is the response rate for the chemotherapy you'd
receive as 3rd(?) line treatment? 2) Many of the immunotherapy clinical trials have an exclusion if
you've had any prior immunotherapy treatment.”

• “I would try (bazedoxifene) in a heartbeat if current treatment tamoxifen fails and I could get it.”
• “My onc is at the Cleveland Clinic and just offered (Torisel) to me. He gave me the choice of avastin
and three other drugs. He thought that temsirolimus would be the best choice along with avastin.”

Brian Loew, brian@inspire.com, @teaminspire
Thursday, February 13, 14

www.Inspire.com
Discovery

Brian Loew, brian@inspire.com, @teaminspire
Thursday, February 13, 14

www.Inspire.com
Discovery

When someone recently started a discussion about privacy issues, I got a little concerned that too
much privacy might have prevented me from finding what has been the most useful, supportive
group for me.

Brian Loew, brian@inspire.com, @teaminspire
Thursday, February 13, 14

www.Inspire.com
The “Tarceva Diva,” and her Divas & Dudes
• In Inspire’s Lung Cancer Survivors Support Community, one now-deceased member,

“MarieZee100,” began a discussion topic--on her own--to connect people who are or were on
Tarceva

• In just her “Tarceva Divas” discussion strings alone, apx. 8,000 posts by members, over apx. 30
months

• Discussed not just Tarceva itself, but new drugs and combination therapies
• Strength of self-organized “sub-community”--MarieZee100 has died of lung cancer, but another

member picked up the “Tarceva Diva” mantle, and the discussion topic continues stronger than
ever.

Brian Loew, brian@inspire.com, @teaminspire
Thursday, February 13, 14

www.Inspire.com
A rare disease patient’s story

Brian Loew, brian@inspire.com, @teaminspire
Thursday, February 13, 14

www.Inspire.com
Discovery, as a community finds itself

Brian Loew, brian@inspire.com, @teaminspire
Thursday, February 13, 14

www.Inspire.com
Rare disease e-patients’ call to action

Brian Loew, brian@inspire.com, @teaminspire
Thursday, February 13, 14

www.Inspire.com
Takeaways:

Patients are engaged in seeking and sharing detailed
information about pre-approval therapies.

Many patients want to contribute to research.
Technology matters a great deal.
Technology doesn’t matter at all.

Brian Loew, brian@inspire.com, @teaminspire
Thursday, February 13, 14

www.Inspire.com

More Related Content

More from Inspire

Pulmonary Fibrosis Patient/Caregiver Experience​ Survey
Pulmonary Fibrosis Patient/Caregiver Experience​ SurveyPulmonary Fibrosis Patient/Caregiver Experience​ Survey
Pulmonary Fibrosis Patient/Caregiver Experience​ SurveyInspire
 
Patient experience: The first billion words
Patient experience: The first billion wordsPatient experience: The first billion words
Patient experience: The first billion wordsInspire
 
Design Trials to Better Satisfy Patient Centric Outcomes Prior to Product Launch
Design Trials to Better Satisfy Patient Centric Outcomes Prior to Product LaunchDesign Trials to Better Satisfy Patient Centric Outcomes Prior to Product Launch
Design Trials to Better Satisfy Patient Centric Outcomes Prior to Product LaunchInspire
 
What Do Patients Really Want Out Of Adherence Technology?
What Do Patients Really Want Out Of Adherence Technology?What Do Patients Really Want Out Of Adherence Technology?
What Do Patients Really Want Out Of Adherence Technology?Inspire
 
Advocacy in the Digital Age: Leveraging the Mental Health America/Inspire Sup...
Advocacy in the Digital Age: Leveraging the Mental Health America/Inspire Sup...Advocacy in the Digital Age: Leveraging the Mental Health America/Inspire Sup...
Advocacy in the Digital Age: Leveraging the Mental Health America/Inspire Sup...Inspire
 
Insights into the e-Patient: An Analysis of the Inspire Annual Survey
Insights into the e-Patient:  An Analysis of the Inspire Annual SurveyInsights into the e-Patient:  An Analysis of the Inspire Annual Survey
Insights into the e-Patient: An Analysis of the Inspire Annual SurveyInspire
 
Experts by Experience 2015: A compilation of patients’ stories
Experts by Experience 2015: A compilation of patients’ storiesExperts by Experience 2015: A compilation of patients’ stories
Experts by Experience 2015: A compilation of patients’ storiesInspire
 
TalkPsoriasis: 50,000 members strong
TalkPsoriasis: 50,000 members strong TalkPsoriasis: 50,000 members strong
TalkPsoriasis: 50,000 members strong Inspire
 
Voice of the Empowered Patient: An Analysis of the Inspire Annual Survey
Voice of the Empowered Patient:  An Analysis of the Inspire Annual SurveyVoice of the Empowered Patient:  An Analysis of the Inspire Annual Survey
Voice of the Empowered Patient: An Analysis of the Inspire Annual SurveyInspire
 
Real World Takeaway Strategies for Successful Partnerships
Real World Takeaway Strategies for Successful PartnershipsReal World Takeaway Strategies for Successful Partnerships
Real World Takeaway Strategies for Successful PartnershipsInspire
 
Don’t Fail to Communicate – Identify Patient Perceptions of Communication Gap...
Don’t Fail to Communicate – Identify Patient Perceptions of Communication Gap...Don’t Fail to Communicate – Identify Patient Perceptions of Communication Gap...
Don’t Fail to Communicate – Identify Patient Perceptions of Communication Gap...Inspire
 
Beyond Privacy: Social Media’s Ethical Responsibility to the Clinical Trial P...
Beyond Privacy: Social Media’s Ethical Responsibility to the Clinical Trial P...Beyond Privacy: Social Media’s Ethical Responsibility to the Clinical Trial P...
Beyond Privacy: Social Media’s Ethical Responsibility to the Clinical Trial P...Inspire
 
Scleroderma Foundation/Inspire Support Community at a Glance
Scleroderma Foundation/Inspire Support Community at a Glance Scleroderma Foundation/Inspire Support Community at a Glance
Scleroderma Foundation/Inspire Support Community at a Glance Inspire
 
Strategies and Tactics to Leverage Social and Digital Media in Clinical Rese...
Strategies and Tactics to Leverage Social and Digital Media in Clinical Rese...Strategies and Tactics to Leverage Social and Digital Media in Clinical Rese...
Strategies and Tactics to Leverage Social and Digital Media in Clinical Rese...Inspire
 
Advancing Quality of Care for Tuberous Sclerosis Complex Patients: A Case St...
 Advancing Quality of Care for Tuberous Sclerosis Complex Patients: A Case St... Advancing Quality of Care for Tuberous Sclerosis Complex Patients: A Case St...
Advancing Quality of Care for Tuberous Sclerosis Complex Patients: A Case St...Inspire
 
Experts by experience 2014: A compilation of patients’ stories
Experts by experience 2014: A compilation of patients’ storiesExperts by experience 2014: A compilation of patients’ stories
Experts by experience 2014: A compilation of patients’ storiesInspire
 
Lives Turned Upside Down: The Impact of Sarcoidosis
Lives Turned Upside Down: The Impact of SarcoidosisLives Turned Upside Down: The Impact of Sarcoidosis
Lives Turned Upside Down: The Impact of SarcoidosisInspire
 
Inspire Rare Disease Health Communities at a Glance
Inspire Rare Disease Health Communities at a GlanceInspire Rare Disease Health Communities at a Glance
Inspire Rare Disease Health Communities at a GlanceInspire
 
Trialing successful social media strategies in clinical research & development
Trialing successful social media strategies in clinical research & developmentTrialing successful social media strategies in clinical research & development
Trialing successful social media strategies in clinical research & developmentInspire
 
Closing perception gaps between patients and their caregivers
Closing perception gaps between patients and their caregiversClosing perception gaps between patients and their caregivers
Closing perception gaps between patients and their caregiversInspire
 

More from Inspire (20)

Pulmonary Fibrosis Patient/Caregiver Experience​ Survey
Pulmonary Fibrosis Patient/Caregiver Experience​ SurveyPulmonary Fibrosis Patient/Caregiver Experience​ Survey
Pulmonary Fibrosis Patient/Caregiver Experience​ Survey
 
Patient experience: The first billion words
Patient experience: The first billion wordsPatient experience: The first billion words
Patient experience: The first billion words
 
Design Trials to Better Satisfy Patient Centric Outcomes Prior to Product Launch
Design Trials to Better Satisfy Patient Centric Outcomes Prior to Product LaunchDesign Trials to Better Satisfy Patient Centric Outcomes Prior to Product Launch
Design Trials to Better Satisfy Patient Centric Outcomes Prior to Product Launch
 
What Do Patients Really Want Out Of Adherence Technology?
What Do Patients Really Want Out Of Adherence Technology?What Do Patients Really Want Out Of Adherence Technology?
What Do Patients Really Want Out Of Adherence Technology?
 
Advocacy in the Digital Age: Leveraging the Mental Health America/Inspire Sup...
Advocacy in the Digital Age: Leveraging the Mental Health America/Inspire Sup...Advocacy in the Digital Age: Leveraging the Mental Health America/Inspire Sup...
Advocacy in the Digital Age: Leveraging the Mental Health America/Inspire Sup...
 
Insights into the e-Patient: An Analysis of the Inspire Annual Survey
Insights into the e-Patient:  An Analysis of the Inspire Annual SurveyInsights into the e-Patient:  An Analysis of the Inspire Annual Survey
Insights into the e-Patient: An Analysis of the Inspire Annual Survey
 
Experts by Experience 2015: A compilation of patients’ stories
Experts by Experience 2015: A compilation of patients’ storiesExperts by Experience 2015: A compilation of patients’ stories
Experts by Experience 2015: A compilation of patients’ stories
 
TalkPsoriasis: 50,000 members strong
TalkPsoriasis: 50,000 members strong TalkPsoriasis: 50,000 members strong
TalkPsoriasis: 50,000 members strong
 
Voice of the Empowered Patient: An Analysis of the Inspire Annual Survey
Voice of the Empowered Patient:  An Analysis of the Inspire Annual SurveyVoice of the Empowered Patient:  An Analysis of the Inspire Annual Survey
Voice of the Empowered Patient: An Analysis of the Inspire Annual Survey
 
Real World Takeaway Strategies for Successful Partnerships
Real World Takeaway Strategies for Successful PartnershipsReal World Takeaway Strategies for Successful Partnerships
Real World Takeaway Strategies for Successful Partnerships
 
Don’t Fail to Communicate – Identify Patient Perceptions of Communication Gap...
Don’t Fail to Communicate – Identify Patient Perceptions of Communication Gap...Don’t Fail to Communicate – Identify Patient Perceptions of Communication Gap...
Don’t Fail to Communicate – Identify Patient Perceptions of Communication Gap...
 
Beyond Privacy: Social Media’s Ethical Responsibility to the Clinical Trial P...
Beyond Privacy: Social Media’s Ethical Responsibility to the Clinical Trial P...Beyond Privacy: Social Media’s Ethical Responsibility to the Clinical Trial P...
Beyond Privacy: Social Media’s Ethical Responsibility to the Clinical Trial P...
 
Scleroderma Foundation/Inspire Support Community at a Glance
Scleroderma Foundation/Inspire Support Community at a Glance Scleroderma Foundation/Inspire Support Community at a Glance
Scleroderma Foundation/Inspire Support Community at a Glance
 
Strategies and Tactics to Leverage Social and Digital Media in Clinical Rese...
Strategies and Tactics to Leverage Social and Digital Media in Clinical Rese...Strategies and Tactics to Leverage Social and Digital Media in Clinical Rese...
Strategies and Tactics to Leverage Social and Digital Media in Clinical Rese...
 
Advancing Quality of Care for Tuberous Sclerosis Complex Patients: A Case St...
 Advancing Quality of Care for Tuberous Sclerosis Complex Patients: A Case St... Advancing Quality of Care for Tuberous Sclerosis Complex Patients: A Case St...
Advancing Quality of Care for Tuberous Sclerosis Complex Patients: A Case St...
 
Experts by experience 2014: A compilation of patients’ stories
Experts by experience 2014: A compilation of patients’ storiesExperts by experience 2014: A compilation of patients’ stories
Experts by experience 2014: A compilation of patients’ stories
 
Lives Turned Upside Down: The Impact of Sarcoidosis
Lives Turned Upside Down: The Impact of SarcoidosisLives Turned Upside Down: The Impact of Sarcoidosis
Lives Turned Upside Down: The Impact of Sarcoidosis
 
Inspire Rare Disease Health Communities at a Glance
Inspire Rare Disease Health Communities at a GlanceInspire Rare Disease Health Communities at a Glance
Inspire Rare Disease Health Communities at a Glance
 
Trialing successful social media strategies in clinical research & development
Trialing successful social media strategies in clinical research & developmentTrialing successful social media strategies in clinical research & development
Trialing successful social media strategies in clinical research & development
 
Closing perception gaps between patients and their caregivers
Closing perception gaps between patients and their caregiversClosing perception gaps between patients and their caregivers
Closing perception gaps between patients and their caregivers
 

Recently uploaded

AORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissectionAORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissectiondrhanifmohdali
 
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptxORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptxNIKITA BHUTE
 
Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024Peter Embi
 
Adenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisAdenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisSujoy Dasgupta
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxMAsifAhmad
 
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfSGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfHongBiThi1
 
power point presentation of Clinical evaluation of strabismus
power point presentation of Clinical evaluation  of strabismuspower point presentation of Clinical evaluation  of strabismus
power point presentation of Clinical evaluation of strabismusChandrasekar Reddy
 
Basic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxBasic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxkomalt2001
 
Mental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil ThirusanguMental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil Thirusangu Medical University
 
MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.whalesdesign
 
blood bank management system project report
blood bank management system project reportblood bank management system project report
blood bank management system project reportNARMADAPETROLEUMGAS
 
High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)kishan singh tomar
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfHongBiThi1
 
AUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsAUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsMedicoseAcademics
 
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.aarjukhadka22
 
Red Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfRed Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfMedicoseAcademics
 
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfCONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfDolisha Warbi
 

Recently uploaded (20)

AORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissectionAORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissection
 
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptxORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
 
Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024
 
Biologic therapy ice breaking in rheumatology, Case based approach with appli...
Biologic therapy ice breaking in rheumatology, Case based approach with appli...Biologic therapy ice breaking in rheumatology, Case based approach with appli...
Biologic therapy ice breaking in rheumatology, Case based approach with appli...
 
Adenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisAdenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosis
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
 
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfSGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
 
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
 
power point presentation of Clinical evaluation of strabismus
power point presentation of Clinical evaluation  of strabismuspower point presentation of Clinical evaluation  of strabismus
power point presentation of Clinical evaluation of strabismus
 
Basic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxBasic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptx
 
Mental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil ThirusanguMental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil Thirusangu
 
MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.
 
blood bank management system project report
blood bank management system project reportblood bank management system project report
blood bank management system project report
 
How to master Steroid (glucocorticoids) prescription, different scenarios, ca...
How to master Steroid (glucocorticoids) prescription, different scenarios, ca...How to master Steroid (glucocorticoids) prescription, different scenarios, ca...
How to master Steroid (glucocorticoids) prescription, different scenarios, ca...
 
High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
 
AUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsAUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functions
 
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
 
Red Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfRed Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdf
 
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfCONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
 

How e-Patients are Learning and Sharing Information about Pre-Approval Therapies

  • 1. How e-Patients are Learning and Sharing Information about Pre-Approval Therapies brian@inspire.com @teaminspire Patient-Centered Technologies for Post-Marketing and Real World Data Research February 6, 2014 Brian Loew, CEO, Inspire www.Inspire.com Thursday, February 13, 14
  • 2. Patients are increasingly seeking and sharing information online about drugs before FDA approval Examples from our ovarian, lung, prostate and advanced breast cancer groups: • “About temsirolimus: Right after my cancer returned 3 months after the completion of the taxol-platinum regimen, my doctor sent me to the U of Penn to enroll in a study...I was delighted to find that it was reducing the size of my tumor, though it never completely eliminated it.” • “If the resistance to Tarceva is due to the T790M mutation, there are two promising drugs in clinical trials right now. One is from Clovis called CO-1686, the other from AstraZeneca called AZD9291.” • “Nivolumab 3mg/kg every 2 weeks HAS worked for me one tumor so small no longer measurable. I knew it was working as I just felt better almost immediately.” Brian Loew, brian@inspire.com, @teaminspire Thursday, February 13, 14 www.Inspire.com
  • 3. More sharing–driven entirely by engaged, insightful patients: • “The phase 3 trial that is just starting is using Mekinist, which is FDA approved for Melanoma. Your doc should make a case to your insurance to cover this drug for your treatment and start you on it outside of the trial.” • “There is a drug in prostate cancer that targets CLTA-4 in clinical trials.” • “When deciding between continuing on anti-PD1 trial or switching to chemotherapy, I think you need to consider at least two things: 1) What is the response rate for the chemotherapy you'd receive as 3rd(?) line treatment? 2) Many of the immunotherapy clinical trials have an exclusion if you've had any prior immunotherapy treatment.” • “I would try (bazedoxifene) in a heartbeat if current treatment tamoxifen fails and I could get it.” • “My onc is at the Cleveland Clinic and just offered (Torisel) to me. He gave me the choice of avastin and three other drugs. He thought that temsirolimus would be the best choice along with avastin.” Brian Loew, brian@inspire.com, @teaminspire Thursday, February 13, 14 www.Inspire.com
  • 4. Discovery Brian Loew, brian@inspire.com, @teaminspire Thursday, February 13, 14 www.Inspire.com
  • 5. Discovery When someone recently started a discussion about privacy issues, I got a little concerned that too much privacy might have prevented me from finding what has been the most useful, supportive group for me. Brian Loew, brian@inspire.com, @teaminspire Thursday, February 13, 14 www.Inspire.com
  • 6. The “Tarceva Diva,” and her Divas & Dudes • In Inspire’s Lung Cancer Survivors Support Community, one now-deceased member, “MarieZee100,” began a discussion topic--on her own--to connect people who are or were on Tarceva • In just her “Tarceva Divas” discussion strings alone, apx. 8,000 posts by members, over apx. 30 months • Discussed not just Tarceva itself, but new drugs and combination therapies • Strength of self-organized “sub-community”--MarieZee100 has died of lung cancer, but another member picked up the “Tarceva Diva” mantle, and the discussion topic continues stronger than ever. Brian Loew, brian@inspire.com, @teaminspire Thursday, February 13, 14 www.Inspire.com
  • 7. A rare disease patient’s story Brian Loew, brian@inspire.com, @teaminspire Thursday, February 13, 14 www.Inspire.com
  • 8. Discovery, as a community finds itself Brian Loew, brian@inspire.com, @teaminspire Thursday, February 13, 14 www.Inspire.com
  • 9. Rare disease e-patients’ call to action Brian Loew, brian@inspire.com, @teaminspire Thursday, February 13, 14 www.Inspire.com
  • 10. Takeaways: Patients are engaged in seeking and sharing detailed information about pre-approval therapies. Many patients want to contribute to research. Technology matters a great deal. Technology doesn’t matter at all. Brian Loew, brian@inspire.com, @teaminspire Thursday, February 13, 14 www.Inspire.com